...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Sedum sarmentosum Bunge extract ameliorates lipopolysaccharide- and D-galactosamine-induced acute liver injury by attenuating the hedgehog signaling pathway via regulation of miR-124 expression
【24h】

Sedum sarmentosum Bunge extract ameliorates lipopolysaccharide- and D-galactosamine-induced acute liver injury by attenuating the hedgehog signaling pathway via regulation of miR-124 expression

机译:Sedum Sarmentosum Bunge提取物通过调节miR-124表达来减少刺猬信号通路来改善脂多糖和D-半乳糖胺诱导的急性肝损伤

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Sedum sarmentosum is traditionally used to treat various inflammatory diseases in China. It has protective effects against acute liver injury, but the exact mechanism of such effects remains unclear. This study investigated the protective effects of S. sarmentosum extract on lipopolysaccharide (LPS)/D-galactosamine (D-GalN)-induced acute liver injury in mice and the mechanism of such effects. Mice were randomly divided into control, treatment, model, and model treatment groups. Acute liver injury was induced in model mice via intraperitoneal injection of LPS and D-GalN with doses of 10?μg/kg of LPS and 500?mg/kg, respectively. The mRNA expression levels of miR-124, Hedgehog, Patched (Ptch), Smoothened (Smo), and glioma-associated oncogene homolog (Gli) in liver tissues were determined through RT-PCR, and the protein levels of Hedgehog, Ptch, Smo, Gli, P13k, Akt, HMGB1, TLR4, IkB-α, p-IkB-α, and NF-kB65 were evaluated via Western blot analysis. The serum levels of IL-6, TNF-α, CRP, IL-12, and ICAM-1 were determined via ELISA. TLR4 and NF-κBp65 activity and the levels of DNA-bound NF-KB65 and TLR4 in LPS/D-GalN-induced liver tissues were also determined. We recorded the time of death, plotted the survival curve, and calculated the liver index. We then observed the pathological changes in liver tissue and detected the levels of liver enzymes (alanine aminotransferase [ALT] and aspartate transaminase [AST]) in the serum and myeloperoxidase (MPO) and plasma inflammatory factors in the liver homogenate. Afterward, we evaluated the protective effects of S. sarmentosum extracts on acute liver injury in mice. Results showed that after S. sarmentosum extract was administered, the expression level of miR-124 increased in liver tissues. However, the protein expression levels of Hedgehog, Ptch, Smo, Gli, P13k, p-Akt, HMGB1, TLR4, p-IκB-α, and NF-κB65 and the mRNA expression levels of Hedgehog, Ptch, Smo, and Gli decreased. The MPO level in the liver, the IL-6, TNF-α, CRP, IL-12, and MMP-9 levels in the plasma, and the serum ALT and AST levels also decreased, thereby reducing LPS/D-GalN-induced liver injury and improving the survival rate of liver-damaged animals within 24?h. S. sarmentosum extract can alleviate LPS/D-GalN-induced acute liver injury in mice and improve the survival rate of mice. The mechanism may be related to the increase in miR-124 expression, decrease in Hedgehog and HMGB1 signaling pathway activities, and reduction in inflammatory responses in the liver. Hedgehog is a regulatory target for miR-124.
机译:Sedum Sarmentosum传统上用于治疗中国各种炎症疾病。它对急性肝损伤具有保护作用,但这些效果的确切机制仍然不清楚。本研究调查了S. Sarmentosum提取物对脂多糖(LPS)/ D-半乳糖胺(D-GALN)诱导的小鼠急性肝损伤的保护作用和这种作用的机制。将小鼠随机分为对照,治疗,模型和模型治疗组。通过腹膜内注射急性肝损伤,通过腹膜内注射LPS和D-GALN,剂量为10〜μg/ kg的LPS和500×mg / kg。通过RT-PCR测定miR-124,刺猬,修补(PTCH),平滑(Smo)和胶质瘤相关的癌症和胶质瘤相关的癌基因同源物(GLI)的mRNA表达水平,以及刺猬,PTCH,SMO的蛋白质水平通过Western印迹分析评估Gli,P13K,AKT,HMGB1,TLR4,IKB-α,P-IKB-α和NF-KB65。通过ELISA测定IL-6,TNF-α,CRP,IL-12和ICAM-1的血清水平。还确定了TLR4和NF-κBP65活性和DNA结合的NF-KB65和TLR4在LPS / D-GALN诱导的肝组织中的含量。我们记录了死亡的时间,绘制了存活曲线,并计算了肝脏指数。然后,我们观察到肝脏组织的病理变化,并检测在血清和髓过氧化物酶(MPO)中的肝酶(丙氨酸氨基转移酶[ALT]和天冬氨酸转氨酶[AST])和肝脏匀浆中的血浆炎症因子。之后,我们评估了S. Sarmentosum提取物对小鼠急性肝损伤的保护作用。结果表明,施用S. S.Sarmentosum提取物后,MiR-124的表达水平在肝组织中增加。然而,刺猬,PTCH,SMO,GLI,P13K,P-AKT,HMGB1,TLR4,P-IκB-α和NF-κB65以及刺猬,PTCH,SMO和GLI的mRNA表达水平的蛋白质表达水平降低。肝脏中的MPO水平,血浆中的IL-6,TNF-α,CRP,IL-12和MMP-9水平以及血清ALT和AST水平也降低,从而减少了LPS / D-GALN诱导的肝损伤并提高肝脏受损动物的存活率在24℃内。 S. Sarmentosum提取物可以缓解小鼠的LPS / D-Galn诱导的急性肝损伤,提高小鼠的存活率。该机制可能与miR-124表达的增加有关,刺猬和HMGB1信号通路活动的增加,以及肝脏中炎症反应的降低。 Hedgehog是MIR-124的监管目标。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号